Tag:
Form 483
Latest Headlines
Latest Headlines
Novartis plant's quality control understaffed, inadequately trained, FDA says
Novartis ( $NVS ) temporarily pulled the curtains on its Lincoln, NE, consumer drug plant in late December. What's been going on behind those windows? Pharmalot reports that, after a recent visit, FDA
Another J&J plant cited for problems
Embattled Johnson & Johnson ( NYSE: JNJ ), already under intense scrutiny over conditions at a Pennsylvania plant that makes children's pain and cold drugs, is now being cited for problems at
